OsMo
OsMo is a lysosome-targeting hNEU1 inhibitor that can be used in the study of myocardial injury[1].
Product Specifications
UNSPSC
12352005
Target
Autophagy; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/osmo.html
Smiles
O=C(C1=C[C@H]([C@@H]([C@H](C1)N)NC(C)=O)OC(CC)CC)OCCN2CCOCC2
Molecular Formula
C20H35N3O5
Molecular Weight
397.51
References & Citations
[1]Zhou W, et al. A Lysosome-Targeting hNEU1 Inhibitor Treats Myocardial Infarction: A Potential Therapeutic Breakthrough. J Med Chem. 2024 Sep 26;67 (18) :16899-16911.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
AE23112RA-01 48 Tests
Rat ATP-binding cassette sub-family B member 9 (ABCB9) ELISA Kit
Sign In for Pricing
View Details 
AE23112RA-02 96 Tests
Rat ATP-binding cassette sub-family B member 9 (ABCB9) ELISA Kit
Sign In for Pricing
View Details